EZR and neoplasm: The percentages of positive ezrin, ezrinThr-567 and ezrinTyr-353 cells in adjacent non-tumor tissues were 31.3%, 14.0% and 11.3%, respectively, and 35.7%, 14.3% and 7.1% in normal lung tissue counterparts, respectively.